ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) | Grant Type | Year |
State |
|---|---|---|---|---|
| The role of NOTCH1 in T-cell acute lymphoblastic leukemia. | Columbia University Medical Center / Adolfo Ferrando | Bridge Grants | 2012 | New York |
| BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia | Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD | 'A' Award Grants | 2012 | New York |
| Epigenetic Modifiers as Therapeutic Targets in Pediatric T-cell Acute Lymphoblastic Leukemia | Washington University / Grant Challen, PhD | 'A' Award Grants | 2012 | Missouri |
| Neurofibromatosis Type 1 as a model population for pediatric brain cancer prevention and control research | Washington University / Kimberly Johnson Ph.D. | Epidemiology Grants | 2012 | Missouri |
| Development of the Next Generation FLT3 Inhibitors for Pediatric AML and Infant ALL | The Johns Hopkins University School of Medicine / Donald Small, MD, PhD | Innovation Grants | 2012 | Maryland |
| Discovery of New Targets and Pathways for T-ALL Therapy | Dana-Farber Cancer Institute / Thomas Look | Bridge Grants | 2012 | Massachusetts |
| Selective inhibition of nuclear export as a novel therapeutic strategy in AML | Dana-Farber Cancer Institute / Julia Etchin | Young Investigator Grants | 2012 | Massachusetts |
| Investigating the Role of the RNA Binding Protein LIN28 in Neuroblastoma | Boston Children’s Hospital / John Powers | Young Investigator Grants | 2012 | Massachusetts |
| Searching for genetic vulnerabilities in osteosarcoma through genome-wide RNAi screening | Dana-Farber Cancer Institute / Stuart Orkin, MD | Innovation Grants | 2012 | Massachusetts |
| Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing sarcoma | Dana-Farber Cancer Institute / Kimberly Stegmaier, MD | Bridge Grants | 2012 | Massachusetts |